An encouraging progress report on the treatment of progeria and its implications for atherogenesis

Circulation. 2014 Jul 1;130(1):4-6. doi: 10.1161/CIRCULATIONAHA.114.010648. Epub 2014 May 2.

¹ From the Department of Pathology (J.O., G.M.M.) and the Division of Medical Genetics (F.M.H.), University of Washington, Seattle, WA; and Molecular Biology Institute, University of California at Los Angeles, Los Angeles, CA (G.M.M.). picard@u.washington.edu.
² From the Department of Pathology (J.O., G.M.M.) and the Division of Medical Genetics (F.M.H.), University of Washington, Seattle, WA; and Molecular Biology Institute, University of California at Los Angeles, Los Angeles, CA (G.M.M.).

No abstract available

Keywords: Editorials; atherosclerosis; clinical trial; farnesyltransferase; genetics; humans; progeria.

Publication types